Bavencio 200 mg ( 20 mg/ml) (Avelumab)

DADirect awardda35002732SSS.C. GRAL MEDICAL S.R.L.
Estimated valueRON 35,210
DeadlineExpired8 Feb 2024, 12:35
Competition11 participant
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
da35002732
Contract type
—
Deadline
8 Feb 2024, 12:35
CPV codes
33652000 - Antineoplastic and immunomodulating agents
Status
Awarded
Notice type
DADirect award
Source
SEAP/SICAP
Estimated value
RON 35,210
Publication date
8 Feb 2024, 12:30

Overview

Bavencio 200 mg ( 20 mg/ml) (Avelumab).Prezenta achizitie tine loc de comanda ferma. Livrare: Gral Medical SRL, st.Brestei, nr.21, Craiova, jud.Dolj Plată: op 90zile

Contracting authorities1

SS

CUI 15413404

roBucuresti, Romania
[email protected]

Lots1

Documentation0

Documents have not been synced yet. Last checked 14 Oct 2026, 18:59.

Award criteria0

No procedure-level award criteria recorded.

Participants1

Procured items1